Schroder Investment Management Group Boosts Position in Synopsys, Inc. $SNPS

Schroder Investment Management Group raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 6.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,090 shares of the semiconductor company’s stock after buying an additional 5,145 shares during the period. Schroder Investment Management Group’s holdings in Synopsys were worth $40,502,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Alpine Bank Wealth Management raised its stake in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 25 shares during the period. TFC Financial Management Inc. boosted its position in Synopsys by 1,250.0% during the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares during the period. Millstone Evans Group LLC purchased a new stake in Synopsys during the 3rd quarter worth $27,000. SOA Wealth Advisors LLC. acquired a new stake in Synopsys in the 3rd quarter valued at $28,000. Finally, McIlrath & Eck LLC acquired a new stake in Synopsys in the 3rd quarter valued at $29,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Wells Fargo & Company reduced their price objective on Synopsys from $500.00 to $450.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 26th. Piper Sandler lowered their target price on Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a research note on Thursday, February 26th. The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the company a “buy” rating in a report on Wednesday, February 25th. Citigroup initiated coverage on Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 price target on the stock. Finally, Rosenblatt Securities decreased their price target on Synopsys from $560.00 to $530.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $531.00.

More Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Rolled out new software tools for designing AI chips and integrated Synopsys‑Ansys capabilities that aim to speed design of complex AI systems and support customers like Nvidia and AMD; this strengthens Synopsys’ position in the fast‑growing AI‑chip ecosystem. Synopsys rolls out new software tools for designing AI chips
• Positive Sentiment: Announced hardware‑assisted verification (HAV) enhancements and new FPGA platforms that claim up to 2x performance/capacity for AI‑era chip verification — a direct revenue driver as customers validate larger multi‑die and AI designs. Synopsys Introduces Software-Defined Hardware-Assisted Verification to Enable AI Proliferation
• Positive Sentiment: Launched the Electronics Digital Twin (eDT) Platform focused on automotive electronic systems and early software validation — positioned to capture vehicle OEM spending on software‑defined vehicles and speed time‑to‑market. Synopsys Launches Electronics Digital Twin Platform to Accelerate Physical AI System Development
• Positive Sentiment: Released Ansys 2026 R1 (first major release post‑acquisition) and announced unified Synopsys‑Ansys workflows and AI‑driven simulation features — accelerates cross‑selling opportunities and integration of the $35B Ansys deal. Synopsys Launches Ansys 2026 R1 to Re-Engineer Engineering with Joint Solutions and AI-Powered Products
• Positive Sentiment: Partnered with Movellus to add adaptive clocking tech to Synopsys’ SLM IP, addressing power efficiency for next‑gen AI chips — a niche but relevant IP expansion for power‑constrained designs. Movellus Partners with Synopsys to Deliver Power Efficiency for Next Generation IC’s
• Neutral Sentiment: Analyst/features coverage (Zacks, TipRanks) has put SNPS on watchlists and summarized the new product announcements — useful for sentiment and visibility but not definitive guidance changes. Is Trending Stock Synopsys, Inc. (SNPS) a Buy Now?
• Negative Sentiment: Valuation and near‑term performance questions: coverage notes the stock has been roughly flat over the past year and down over the last 3 months, and investors are weighing the execution risk and cost of integrating the Ansys acquisition against the growth story. Synopsys (SNPS) Valuation Check As Shares Stall And Ansys Deal Reshapes Growth Story

Synopsys Stock Performance

NASDAQ:SNPS opened at $432.98 on Thursday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. The firm has a 50-day moving average of $464.30 and a two-hundred day moving average of $466.18. The stock has a market cap of $82.94 billion, a P/E ratio of 67.23, a PEG ratio of 3.52 and a beta of 1.15. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, beating the consensus estimate of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The company had revenue of $2.41 billion during the quarter, compared to the consensus estimate of $2.39 billion. During the same period last year, the firm earned $3.03 earnings per share. The company’s revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 4,157 shares of company stock valued at $1,945,036. 0.56% of the stock is owned by insiders.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.